SVS Position Statement on Vascular Screening
Vascular disease is among the leading causes of death in the United States, yet is generally asymptomatic until a catastrophic event occurs, such as a stroke or aneurysm rupture.
Vascular disease is among the leading causes of death in the United States, yet is generally asymptomatic until a catastrophic event occurs, such as a stroke or aneurysm rupture.
Many aspects of health care in the United States are the best in the world; however, escalating expense, lack of access and variable quality must be addressed.
As of January 1, 2011, co-insurance for the abdominal aortic aneurysm (AAA) screening benefit in Medicare (G0389) was waived for beneficiaries who qualify for this one-time screening as part of the Welcome to Medicare Physical Exam, which is available during the first twelve months of Medicare el
The Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act passed the full (US) Senate as a last minute amendment to the Finance Committee’s budget reconciliation package in November 2005, but was not included in the House package because Medicare was not addressed.